<DOC>
	<DOC>NCT00927043</DOC>
	<brief_summary>This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.</brief_summary>
	<brief_title>Study Evaluating Renal Cell Carcinoma Risk Factors</brief_title>
	<detailed_description>invitation to volunteer</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Renal Cell</mesh_term>
	<criteria>Treatment naïve patients with proven advanced RCC will be evaluated. (Except surgery or radiotherapy) =18 years, any gender. Patients with advanced Renal Cell Carcinoma and treatment naïve. Patients who have already initiated any kind of specific therapy for the treatment of RCC.2. Patients with other neoplasias different from RCC (current or past).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>